Search

Your search keyword '"Pha Micheline"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Pha Micheline" Remove constraint Author: "Pha Micheline"
133 results on '"Pha Micheline"'

Search Results

1. French protocol for the diagnosis and management of systemic lupus erythematosus

5. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome

6. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

7. Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus

9. Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus

12. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies neutralising IFN-α

13. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic Syndrome

15. Systemic lupus erythematosus-related acute lung disease.

16. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

17. Transition de la médecine pédiatrique à la médecine pour adultes dans les maladies autoimmunes et autoinflammatoires rares

18. Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial

19. Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia

20. Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study

21. Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)

22. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome

23. A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia

24. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus

25. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome

26. Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients

27. Article type: Research letter

28. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

29. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

30. Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study

31. COVID‐19 ‐associated collapsing glomerulopathy: a report of two cases and literature review

32. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.

33. Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study)

36. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

39. Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial

40. Monitoring disease activity in systemic lupus erythematosus with single-molecule array digital ELISA quantification of serum interferon-α

41. Symptomatic muscular sarcoidosis

42. Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse

44. Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter

45. Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics

46. OP0043 WITHDRAWAL OF A LOW DOSE (5 MG) OF CORTICOSTEROIDS IN SYSTEMIC LUPUS IN REMISSION FOR MORE THAN A YEAR IS AT RISK OF RELAPSE – THE CORTICOLUP TRIAL

47. THU0227 BIOLOGICAL MONITORING OF REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS: ABNORMAL SERUM INTERFERON-ALPHA LEVELS PREDICT RELAPSE

48. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single‐Molecule Array Digital Enzyme‐Linked Immunosorbent Assay Quantification of Serum Interferon‐α

49. Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study.

50. Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study).

Catalog

Books, media, physical & digital resources